Glaukos Corp (GKOS)
140.83
-0.61
(-0.43%)
USD |
NYSE |
Nov 21, 16:00
140.78
-0.05
(-0.04%)
Pre-Market: 20:00
Glaukos Debt to Equity Ratio: 0.0849 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0849 |
| June 30, 2024 | 0.0852 |
| March 31, 2024 | 0.6281 |
| December 31, 2023 | 0.6124 |
| September 30, 2023 | 0.5913 |
| June 30, 2023 | 0.5771 |
| March 31, 2023 | 0.5541 |
| December 31, 2022 | 0.5309 |
| September 30, 2022 | 0.5124 |
| June 30, 2022 | 0.4991 |
| March 31, 2022 | 0.4692 |
| December 31, 2021 | 0.4769 |
| September 30, 2021 | 0.4653 |
| June 30, 2021 | 0.4781 |
| March 31, 2021 | 0.4731 |
| December 31, 2020 | 0.2838 |
| September 30, 2020 | 0.2822 |
| June 30, 2020 | 0.2778 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.0276 |
| June 30, 2016 | 0.0503 |
| March 31, 2016 | 0.0765 |
| December 31, 2015 | 0.1019 |
| September 30, 2015 | 0.1251 |
| June 30, 2015 | 0.2208 |
| March 31, 2015 | 3.642 |
| December 31, 2014 | -0.1279 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.6281
Maximum
Mar 2024
0.3941
Average
0.475
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| Baxter International Inc | 1.643 |
| Masimo Corp | 0.528 |
| Teleflex Inc | 0.3924 |
| Perspective Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 926.54M |
| Total Liabilities (Quarterly) | 258.03M |
| Shareholders Equity (Quarterly) | 668.51M |
| Current Ratio | 5.542 |
| Net Debt Paydown Yield | 0.63% |